These results suggest that the chemotherapeutic/gene/photothermal triple therapy of CE7Q/CQ/S may provide an effective strategy for overcoming intrinsic or acquired EGFR-TKI resistance in NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.